FDA ap­proves im­port of French an­tibi­otics to com­bat syphilis drug short­age 

To ad­dress the con­tin­ued short­age of Pfiz­er’s syphilis drug amid ris­ing cas­es in the US, the FDA has ap­proved the tem­po­rary im­port of ex­ten­cilline from France.

Paris-head­quar­tered Lab­o­ra­toires Del­bert’s ex­ten­cilline, while it is not ap­proved in the US, will act as an al­ter­na­tive med­i­cine to Pfiz­er’s Bi­cillin L-A an­tibi­ot­ic, the on­ly FDA-ap­proved treat­ment for the con­gen­i­tal form of syphilis and has been in short­age since April last year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER